Blue Nevus Melanoma Foundation
Public records show a registered, tax-exempt organization in good standing.
What it says it does
A foundation to support research for Blue Nevus Melanoma (BNM). BNM is an ultra rare condition and an aggressive form of Melanoma cancer. There is a dire need to develop new treatments and drugs for it as the standard of care for Melanoma is not effective against Blue Nevus Melanoma.
- Income
- $122,589
- Spending
- $41,779
- Reserves
- 23.8 months of spending
- Largest source of income
- donations and private grants, 100%
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
This organization files the short tax form, which does not ask about boards, policies or audits. That is normal for a small charity and is not a mark against it.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (2)
- $4,597 spent. In 2025, the foundation initiated a research to develop a new drug for Blue Nevus Melanoma (BNM). the foundation supported a UCSF lab to extend their work to also study BNM. In 2025, the foundations grants Research so far supported UCSF lab to collaborate with an external company to screen a large library of 1.2 trillion molecules. The screening identified a handful of candidates that are now being evaluated for further studies as candidate for an initial future medication.
- $2,000 spent. Supported a research to develop Organiods with the Rare Cancer Research Foundation. Organoids allows for faster drug development as they provide a way to simulate new drugs impact in a lab settings. This research attempt was not successful.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.